Alliancebernstein L.P. Kronos Bio, Inc. Transaction History

Alliancebernstein L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$1.44 - $3.44 $4,896 - $11,696	3,400 Added 6.98%	52,100 $84,000
Q3 2022 Nov 15, 2022	BUY	$3.35 - $5.55 $8,040 - $13,320	2,400 Added 5.18%	48,700 $163,000
Q2 2022 Aug 15, 2022	BUY	$3.12 - $7.52 $21,528 - $51,888	6,900 Added 17.51%	46,300 $169,000
Q1 2022 May 13, 2022	BUY	$6.26 - $14.42 $626 - $1,442	100 Added 0.25%	39,400 $285,000
Q2 2021 Jul 30, 2021	BUY	$20.08 - $29.02 $789,143 - $1.14 Million	39,300 New	39,300 $941,000

19.8M

9.3K

100

Ticker KRON
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,769,100
Market Cap $55.1M
Description
Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.